BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3938978)

  • 1. Meningococcal vaccines in prevention and control of meningitis.
    Saxena SN; Rawal IJ; Tripathi KK; Gupta P
    Indian Pediatr; 1985 Jun; 22(6):453-65. PubMed ID: 3938978
    [No Abstract]   [Full Text] [Related]  

  • 2. The capsular polysaccharide of group B Neisseria meningitidis as a vehicle for vaccine development.
    Jennings HJ
    Contrib Microbiol Immunol; 1989; 10():151-65. PubMed ID: 2479499
    [No Abstract]   [Full Text] [Related]  

  • 3. Right age for Meningococcal vaccine.
    John TJ
    Indian Pediatr; 1998 Jul; 35(7):669-70. PubMed ID: 10216680
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vaccines against Neisseria meningitidis].
    Ferrón L; Criado MT; Ferreirós CM
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):296-301. PubMed ID: 1391002
    [No Abstract]   [Full Text] [Related]  

  • 5. [Tetravalent anti-meningococcal vaccine: serologic and clinical evaluation].
    Vescia N; Mastroeni I; Pompa MG; Signorelli C; Fara GM
    Ann Ig; 1989; 1(6):1293-8. PubMed ID: 2484465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second controlled field trial of a serogroup A meningococcal polysaccharide vaccine in Alexandria.
    Wahdan MH; Sallam SA; Hassan MN; Abdel Gawad A; Rakha AS; Sippel JE; Hablas R; Sanborn WR; Kassem NM; Riad SM; Cvjetanović B
    Bull World Health Organ; 1977; 55(6):645-51. PubMed ID: 413639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines against meningococcal meningitis: current status.
    Epidemiol Bull; 1994 Jul; 15(2):13-5. PubMed ID: 8086300
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of Neisseria meningitidis group A polysaccharide vaccine on nasopharyngeal carrier rates.
    Sivonen A
    J Infect; 1981 Sep; 3(3):266-72. PubMed ID: 6821094
    [No Abstract]   [Full Text] [Related]  

  • 9. Meningococci.
    Sippel JE
    Crit Rev Microbiol; 1981; 8(3):267-302. PubMed ID: 6781818
    [No Abstract]   [Full Text] [Related]  

  • 10. [Serogroup A N. meningitidis polysaccharide vaccine and serogroup A N. meningitidis carrier state (author's transl)].
    Bencić Z; Madarić D; Manhalter T; John V; Amsel V; Weisglass H
    Lijec Vjesn; 1978 Nov; 100(11):706-7. PubMed ID: 107385
    [No Abstract]   [Full Text] [Related]  

  • 11. [Survey on efficacy of inoculating purified polysaccharide vaccines as an emergency measure in preventing epidemic meningitis].
    Xu CH
    Zhonghua Liu Xing Bing Xue Za Zhi; 1982 Dec; 3(6):328-30. PubMed ID: 6821030
    [No Abstract]   [Full Text] [Related]  

  • 12. [Preventive effectiveness of an urgent mass vaccination with purified meningococcal polysaccharide vaccine observed during a meningitis epidemic].
    Wu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 1985 Dec; 6(6):344-6. PubMed ID: 3938683
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial retrospective. Meningococcal A and other polysaccharide vaccines. A five-year progress report.
    Lepow ML; Gold R
    N Engl J Med; 1983 May; 308(19):1158-60. PubMed ID: 6403865
    [No Abstract]   [Full Text] [Related]  

  • 14. [Meningococcal disease in the Netherlands; after low tide another high tide?].
    Zanen HC
    Ned Tijdschr Geneeskd; 1984 Mar; 128(11):515-8. PubMed ID: 6424036
    [No Abstract]   [Full Text] [Related]  

  • 15. [Critical review of control strategies for meningococcal meningitis epidemics in Sub-Saharan Africa].
    Chippaux JP; Debois H; Saliou P
    Bull Soc Pathol Exot; 2002 Mar; 95(1):37-44. PubMed ID: 12012963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal meningitis.
    Lancet; 1989 Mar; 1(8639):647-8. PubMed ID: 2564462
    [No Abstract]   [Full Text] [Related]  

  • 17. Development and use of meningococcal vaccines.
    Artenstein S
    Arch Roum Pathol Exp Microbiol; 1974 Jun; 33(2):127-32. PubMed ID: 4213026
    [No Abstract]   [Full Text] [Related]  

  • 18. Status of a group B Neisseria meningitidis vaccine.
    Frasch CE
    Eur J Clin Microbiol; 1985 Dec; 4(6):533-6. PubMed ID: 3937731
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility to meningococcal meningitis.
    Sabath LD; Rosner B
    N Engl J Med; 1973 May; 288(22):1185. PubMed ID: 4633552
    [No Abstract]   [Full Text] [Related]  

  • 20. [Meningococcal meningitis: bacterial virulence, antibodies or complement?].
    Pujadas Capmany R; Jané Pesquer J
    Med Clin (Barc); 1984 Nov; 83(16):671-3. PubMed ID: 6439961
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.